RecruitingPhase 3NCT07181109Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseSponsor: Alnylam PharmaceuticalsAllen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 2NCT07142356A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionSponsor: Retension Pharmaceuticals. Inc.Bellaire, TX · Dallas, TX · Plano, TX · +31 more sites
RecruitingPhase 2NCT06343298To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant HypertensionSponsor: E-Star BioTech, LLCCoppell, TX · Dallas, TX · Denton, TX · +20 more sites